Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP333659.RABiGVOAWAHKf5n_2eD2NXZZjrsuq9NC6L5fkQRV7JD3A130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333659.RABiGVOAWAHKf5n_2eD2NXZZjrsuq9NC6L5fkQRV7JD3A130_provenance.
• NP1142780.RABA2lYvkV74xvh5VUJaoIUyp31T56oFzIZltjmxOHUS8130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1142780.RABA2lYvkV74xvh5VUJaoIUyp31T56oFzIZltjmxOHUS8130_provenance.
• assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP961052.RAaUfN6qASYSXdXZ1OuQ4L0mTTcE77bmkMLpy8fUwqBWk130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961052.RAaUfN6qASYSXdXZ1OuQ4L0mTTcE77bmkMLpy8fUwqBWk130_provenance.
• NP939343.RA78F_1u_YehWY9_jcg-e4OZVqy9R0tEuGrul_N_KjJdE130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939343.RA78F_1u_YehWY9_jcg-e4OZVqy9R0tEuGrul_N_KjJdE130_provenance.
• NP1142783.RA410V3TsYjVOMY2zAzR9kQUzNs9_pSZSHcNR4MAGVWcM130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1142783.RA410V3TsYjVOMY2zAzR9kQUzNs9_pSZSHcNR4MAGVWcM130_provenance.
• NP1142778.RAZNNY-1VoEuWM7XeWTkYI1lOLtFSBbdqvYkRA4ohiWgA130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1142778.RAZNNY-1VoEuWM7XeWTkYI1lOLtFSBbdqvYkRA4ohiWgA130_provenance.
• assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP333823.RAlVH9oqJ_8IFEy5KMt7Eb0rXyxRnKJkX_FcZ56h_8jK0130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333823.RAlVH9oqJ_8IFEy5KMt7Eb0rXyxRnKJkX_FcZ56h_8jK0130_provenance.
• NP973926.RAMnZDD1epURJbYmO-Z0l6aMtmDcKx8GS0w_h8JqP4Qx0130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973926.RAMnZDD1epURJbYmO-Z0l6aMtmDcKx8GS0w_h8JqP4Qx0130_provenance.
• NP954471.RAI04ZlWrn7p3nJvuZSV75xcrEw-EmP12i6V79aKxSBKg130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954471.RAI04ZlWrn7p3nJvuZSV75xcrEw-EmP12i6V79aKxSBKg130_provenance.
• assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1142779.RAi0CpKP-9RH_19MprV2NqsUt_YxlD7AjXAVpllDOe3qY130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1142779.RAi0CpKP-9RH_19MprV2NqsUt_YxlD7AjXAVpllDOe3qY130_provenance.
• NP1142781.RAiVu0ar1X0PNm8XcK5MG1TXxxq_2Lj71fVhhmUG7YR0I130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1142781.RAiVu0ar1X0PNm8XcK5MG1TXxxq_2Lj71fVhhmUG7YR0I130_provenance.
• NP1142782.RAqrCnWjqazaq9sTC8acuPCtsz5wStEwaJP3jRYblOkSM130_assertion description "[The prevalence for methylation of the remaining 38 genes in lung adenocarcinomas from S (n = 97) and NS (n = 75) ranged from 8-89% and significantly differs between S and NS for CPEB1, CST6, EMILIN2, LAYN and MARVELD3 (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1142782.RAqrCnWjqazaq9sTC8acuPCtsz5wStEwaJP3jRYblOkSM130_provenance.